A formulation of canfosfamide consisting of 50 mg/mL canfosfamide hydrochloride in aqueous sodium citrate buffer

• 收藏
• 分享

专利权人:

TELIK; INC.

发明人:

HUGHES, BETSY, R

申请号：

NZ59121309

公开号：

NZ591213A

申请日:

2009.08.04

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

Disclosed is a formulation of canfosfamide consisting essentially of (50±5) mg/mL canfosfamide hydrochloride in (100±10) mM aqueous sodium citrate buffer at pH 4.6±0.2. Also disclosed is a formulation consisting essentially of 50 mg/ mL canfosfamide hydrochloride, 100 mM sodium citrate dihydrate, and 2.9 mM citric acid monohydrate in water at pH 4.6±0.2.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/